Research on GLP-1 receptors in the brain has suggested potential roles in learning, memory, and mood regulation (Durante et al., 2013
Comparative Efficacy: Weight Loss Outcomes (SURMOUNT vs STEP) There are no published head-to-head clinical trials comparing semaglutide and tirzepatide directly
That number jumps to six to nine pounds with lifestyle changes in addition to diabetes medication
At this point, the conclusion was clear
Key risk factors include: History of pancreatitis caution is advised in patients with previous pancreatitis Pre-existing gastrointestinal disease particularly severe gastroparesis or severe GORD Gallbladder disease rapid weight loss itself increases gallstone risk Concurrent medications particularly NSAIDs, anticoagulants, or other drugs affecting gastric mucosa Helicobacter pylori infection if present, may increase ulcer risk independently Diabetic gastroparesis in patients with diabetes, pre-existing delayed gastric emptying may be exacerbated It should be noted that animal studies have shown an increased incidence of thyroid C-cell tumours with semaglutide, though the clinical relevance to humans is unknown
Understanding how Rybelsus works helps explain why nausea and sickness are among its most commonly reported side effects